SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
A BREAKTHROUGH IN PROSTATE CANCER TREATMENT IS NOW AVAILABLE RIGHT HERE IN CINCINNATI, AND ONE LOCAL HOSPITAL AND DOCTOR ARE UTILIZING IT WITH EARLY SUCCESS. WLWT NEWS FIVE’S MEGAN MITCHELL SPOKE ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for ...
This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...
According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...
Nigeria may soon become a medical tourism destination of choice for prostate treatment, following a historic medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback